antibody zo 1 (Proteintech)
Structured Review

Antibody Zo 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 97/100, based on 2587 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zo+1/ZO-1+Antibody/pmc13691533-145-8-12
Average 97 stars, based on 2587 article reviews
Images
1) Product Images from "Electroacupuncture Alleviates Comorbid Depression‐Like Behaviors and Dyspepsia‐Like Symptoms in Rats Accompanied by Alterations in Hippocampal Neuroinflammation and Gut Microbiota"
Article Title: Electroacupuncture Alleviates Comorbid Depression‐Like Behaviors and Dyspepsia‐Like Symptoms in Rats Accompanied by Alterations in Hippocampal Neuroinflammation and Gut Microbiota
Journal: Brain and Behavior
doi: 10.1002/brb3.71854
Figure Legend Snippet: Effects of EA on dyspepsia and intestinal barrier in rats. (A) Observation of the duodenum by TEM. The yellow arrows indicate microvilli, and the green arrows indicate mitochondria. Scale bars = 5 µm. (B) HE staining of the duodenum and stomach, and the number of eosinophils in the duodenum ( n = 3). Scale bars = 100 µm. (C) Small intestinal propulsion rate and gastric emptying rate assay; arrowheads indicate the termination of small intestinal propulsion ( n = 5). (D) MTL and GAS assay ( n = 8). (E–H) IF assay for duodenal tight junction protein ZO‐1 and Occludin protein expression ( n = 3). Scale bars = 100 µm. Data are expressed as mean±SD. ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Techniques Used: H&E Stain, Expressing
Related Articles
Cell-Signaling:Article Title: Alkylating Agent–Induced FANCL Impairment Damages Pulmonary Arterial, Venous, and Microvascular Endothelial Cells and Predisposes to PAH/PVOD Article Snippet: The commercial sources of major reagents and chemicals include: Mitomycin C (MMC, S8146, Selleck, Shanghai, China), Cisplatin (CDDP, MB1055, Meilunbio, Dalian, China), SU5416 (HY‐10374, MedChemExpress, Monmouth Junction, NJ, USA), Amifostine trihydrate (S4298, Selleck, Shanghai, China). .. Primary antibodies for fibronectin (FN, #15613‐I‐AP, Proteintech, Rosemont, IL, USA), Twist (ab50887, Abcam, Cambridge, MA, USA), Vimentin (#5741, Cell Signaling Technology, Danvers, MA, USA), Snail (#ab53519, Abcam, Cambridge, MA, USA), Article Title: TRPV3 drives lung injury by sensing inflammatory signals to disrupt alveolar epithelial barrier and promote inflammation. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82675098, 81972960, 82373929; The Lingang Laboratory Drug Development Project, Grant/Award Number: LGL-2612-09; Double First-Class University Plan, Grant/Award Number: CPU2025CXY02 Abstract Background and Purpose: Pulmonary inflammation is a central pathological feature of many respiratory diseases.. Transient receptor potential vanilloid 3 (TRPV3), a nonselective cation channel abundantly expressed in the skin, nerve and lung tissues, is involved in itch, skin inflammation and barrier regulation.. However, its function in the pulmonary system remains elusive. Control:Article Title: Alkylating Agent–Induced FANCL Impairment Damages Pulmonary Arterial, Venous, and Microvascular Endothelial Cells and Predisposes to PAH/PVOD Article Snippet: The commercial sources of major reagents and chemicals include: Mitomycin C (MMC, S8146, Selleck, Shanghai, China), Cisplatin (CDDP, MB1055, Meilunbio, Dalian, China), SU5416 (HY‐10374, MedChemExpress, Monmouth Junction, NJ, USA), Amifostine trihydrate (S4298, Selleck, Shanghai, China). .. Primary antibodies for fibronectin (FN, #15613‐I‐AP, Proteintech, Rosemont, IL, USA), Twist (ab50887, Abcam, Cambridge, MA, USA), Vimentin (#5741, Cell Signaling Technology, Danvers, MA, USA), Snail (#ab53519, Abcam, Cambridge, MA, USA), Western Blot:Article Title: Alkylating Agent–Induced FANCL Impairment Damages Pulmonary Arterial, Venous, and Microvascular Endothelial Cells and Predisposes to PAH/PVOD Article Snippet: The commercial sources of major reagents and chemicals include: Mitomycin C (MMC, S8146, Selleck, Shanghai, China), Cisplatin (CDDP, MB1055, Meilunbio, Dalian, China), SU5416 (HY‐10374, MedChemExpress, Monmouth Junction, NJ, USA), Amifostine trihydrate (S4298, Selleck, Shanghai, China). .. Primary antibodies for fibronectin (FN, #15613‐I‐AP, Proteintech, Rosemont, IL, USA), Twist (ab50887, Abcam, Cambridge, MA, USA), Vimentin (#5741, Cell Signaling Technology, Danvers, MA, USA), Snail (#ab53519, Abcam, Cambridge, MA, USA), Article Title: TRPV3 drives lung injury by sensing inflammatory signals to disrupt alveolar epithelial barrier and promote inflammation. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82675098, 81972960, 82373929; The Lingang Laboratory Drug Development Project, Grant/Award Number: LGL-2612-09; Double First-Class University Plan, Grant/Award Number: CPU2025CXY02 Abstract Background and Purpose: Pulmonary inflammation is a central pathological feature of many respiratory diseases.. Transient receptor potential vanilloid 3 (TRPV3), a nonselective cation channel abundantly expressed in the skin, nerve and lung tissues, is involved in itch, skin inflammation and barrier regulation.. However, its function in the pulmonary system remains elusive. Immunofluorescence:Article Title: Alkylating Agent–Induced FANCL Impairment Damages Pulmonary Arterial, Venous, and Microvascular Endothelial Cells and Predisposes to PAH/PVOD Article Snippet: The commercial sources of major reagents and chemicals include: Mitomycin C (MMC, S8146, Selleck, Shanghai, China), Cisplatin (CDDP, MB1055, Meilunbio, Dalian, China), SU5416 (HY‐10374, MedChemExpress, Monmouth Junction, NJ, USA), Amifostine trihydrate (S4298, Selleck, Shanghai, China). .. Primary antibodies for fibronectin (FN, #15613‐I‐AP, Proteintech, Rosemont, IL, USA), Twist (ab50887, Abcam, Cambridge, MA, USA), Vimentin (#5741, Cell Signaling Technology, Danvers, MA, USA), Snail (#ab53519, Abcam, Cambridge, MA, USA), Article Title: TRPV3 drives lung injury by sensing inflammatory signals to disrupt alveolar epithelial barrier and promote inflammation. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Numbers: 82675098, 81972960, 82373929; The Lingang Laboratory Drug Development Project, Grant/Award Number: LGL-2612-09; Double First-Class University Plan, Grant/Award Number: CPU2025CXY02 Abstract Background and Purpose: Pulmonary inflammation is a central pathological feature of many respiratory diseases.. Transient receptor potential vanilloid 3 (TRPV3), a nonselective cation channel abundantly expressed in the skin, nerve and lung tissues, is involved in itch, skin inflammation and barrier regulation.. However, its function in the pulmonary system remains elusive. Immunohistochemistry:Article Title: Alkylating Agent–Induced FANCL Impairment Damages Pulmonary Arterial, Venous, and Microvascular Endothelial Cells and Predisposes to PAH/PVOD Article Snippet: The commercial sources of major reagents and chemicals include: Mitomycin C (MMC, S8146, Selleck, Shanghai, China), Cisplatin (CDDP, MB1055, Meilunbio, Dalian, China), SU5416 (HY‐10374, MedChemExpress, Monmouth Junction, NJ, USA), Amifostine trihydrate (S4298, Selleck, Shanghai, China). .. Primary antibodies for fibronectin (FN, #15613‐I‐AP, Proteintech, Rosemont, IL, USA), Twist (ab50887, Abcam, Cambridge, MA, USA), Vimentin (#5741, Cell Signaling Technology, Danvers, MA, USA), Snail (#ab53519, Abcam, Cambridge, MA, USA), Staining:Article Title: Alkylating Agent–Induced FANCL Impairment Damages Pulmonary Arterial, Venous, and Microvascular Endothelial Cells and Predisposes to PAH/PVOD Article Snippet: The commercial sources of major reagents and chemicals include: Mitomycin C (MMC, S8146, Selleck, Shanghai, China), Cisplatin (CDDP, MB1055, Meilunbio, Dalian, China), SU5416 (HY‐10374, MedChemExpress, Monmouth Junction, NJ, USA), Amifostine trihydrate (S4298, Selleck, Shanghai, China). .. Primary antibodies for fibronectin (FN, #15613‐I‐AP, Proteintech, Rosemont, IL, USA), Twist (ab50887, Abcam, Cambridge, MA, USA), Vimentin (#5741, Cell Signaling Technology, Danvers, MA, USA), Snail (#ab53519, Abcam, Cambridge, MA, USA), Chloramphenicol Acetyltransferase Assay:Article Title: Ginsenoside Ra1 alleviates endothelial barrier dysfunction and multi-organ injury in experimental sepsis via NMMHC IIA inhibition. Article Snippet: Funding information Graduate Research and Innovation Projects of Jiangsu Province, Grant/Award Number: KYCX24_1030; National Natural Science Foundation of China, Grant/Award Number: 82574655 Background and Purpose: Non-muscle myosin heavy chain IIA (NMMHC IIA) has emerged as a significant therapeutic target in vascular diseases and sepsis.. However, effective interventions targeting NMMHC IIA in sepsis-induced endothelial dysfunction remain unelucidated.. Here, we have assessed ginsenoside Ra1 (Ra1) as a potent NMMHC IIA inhibitor and evaluate its efficacy and underlying mechanisms in sepsis. Incubation:Article Title: Forsythiae Fructus polysaccharides mitigate DSS colitis by modulating gut microbiota-derived palmitic acid and PI3K/AKT pathway. Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article. |

